Mon.Apr 17, 2023

article thumbnail

New Hepatitis B Testing Guidelines Include Universal Adult Screening

Drug Topics

The CDC said that the new guidance will help identify more cases earlier for better treatment outcomes.

469
469
article thumbnail

Overcoming Analytical Challenges for Gene Therapies

PharmaVoice

Gain a deep understanding of the analytical challenges that gene therapy developers face, and how a strategic partnership with a specialized CRO can offer a competitive advantage in accelerating timelines and improving program success.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How To Mitigate Anorexia and Bulimia in Adolescents With Type 1 Diabetes

Drug Topics

At the 44th National Association of Pediatric Nurse Practitioners Conference, a session presented data explaining why teenagers with T1D are at high risk for developing anorexia and bulimia.

462
462
article thumbnail

Patient influencers are here to stay — where are the regulations?

PharmaVoice

As social media health influencers enter the world of pharma advertising, experts warn that more guardrails are needed to protect the industry and patients.

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Updates To CDC Immunization Schedule

Drug Topics

At the 44th annual National Association of Pediatric Nurse Practitioners Conference, the CDC provided an updated immunization schedule that details new changes.

article thumbnail

FDA Approves Rizatriptan Benzoate Oral Film to Treat Acute Migraine

Pharmacy Times

The efficacy and tolerability of rizatriptan for acute migraine treatment has been well established.

FDA 123

More Trending

article thumbnail

“Tampon Tax” Represents an Inequity

Pharmacy Times

Other health essentials, such as groceries, prescriptions, some OTC medications, are tax-exempt in many states.

123
123
article thumbnail

Sanofi Acquisition Will Further Distribution of T1D Therapy Teplizumab-mzwv

Drug Topics

The drug is the first and only therapy to delay the onset of stage 3 type 1 diabetes.

247
247
article thumbnail

Study Suggests C. Difficile May Be a Foodborne Illness

Pharmacy Times

The 2 most hypervirulent strains of Clostridioides difficile are associated with the consumption of pork and shellfish.

123
123
article thumbnail

14M people could lose dental coverage as Medicaid redeterminations restart: report

Fierce Healthcare

14M people could lose dental coverage as Medicaid redeterminations restart: report pminemyer Mon, 04/17/2023 - 15:58

116
116
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pharmacy Students Experience Compounded Mental Health Stigmas

Pharmacy Times

Some classes and curricula can contribute to preexisting stigmas about drugs and treatments for mental health.

article thumbnail

HHS releases free online cybersecurity training, best practice reports for healthcare

Fierce Healthcare

HHS releases free online cybersecurity training, best practice reports for healthcare dmuoio Mon, 04/17/2023 - 15:49

116
116
article thumbnail

Critical Success Factors for Commercializing Specialty Drugs, Cell and Gene Therapies

Pharmacy Times

Although payers have become somewhat accustomed to the high cost of specialty drugs, the price tags for gene therapies are causing “sticker shock.

123
123
article thumbnail

CVS taps former Humana exec Brian Kane to lead Aetna

Fierce Healthcare

CVS taps former Humana exec Brian Kane to lead Aetna pminemyer Mon, 04/17/2023 - 16:57

111
111
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Study: COVID-19 Infection Spreads Through Households Via Common Surfaces, Hands

Pharmacy Times

The data support the use of interventions at home, including frequent handwashing, physical distancing, regular surface disinfection, and wearing a mask.

123
123
article thumbnail

Charles Redfield to step down as Walmart’s chief merchandising officer

Drug Store News

According to a Wall Street Journal report, Redfield will leave the role on May 1, and the company will announce his replacement soon.

106
106
article thumbnail

Tafasitamab Combination Provides Prolonged, Durable Response in Patients with Aggressive DLBCL

Pharmacy Times

According to 5-year follow-up data, the combination of tafasitamab-cxix and lenalidomide produced a durable response in patients with diffuse large B-cell lymphoma.

122
122
article thumbnail

Merck to develop mAb through $10.8b acquisition

European Pharmaceutical Review

Merck & Co. Inc has agreed to acquire Prometheus Biosciences for $10.8 billion. The agreement is set to help advance PRA023, a novel humanised monoclonal antibody (mAb), developed by Prometheus. Its chosen indications are ulcerative colitis (UC) and Crohn’s disease (CD) and other autoimmune conditions. Prometheus is a clinical-stage biotechnology company.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

HIMSS23: Philips, Intermountain executives call for tech partnerships focused on thoughtful innovation to address burnout

Fierce Healthcare

HIMSS23: Philips, Intermountain executives call for tech partnerships focused on thoughtful innovation to address burnout aburky Mon, 04/17/2023 - 18:20

105
105
article thumbnail

Merck agrees to acquire Prometheus Biosciences for $10.8bn

Pharmaceutical Technology

Merck has signed a definitive agreement to buy clinical-stage biotechnology firm Prometheus Biosciences for $10.8bn, strengthening its immunology pipeline. The company will buy all of Prometheus Biosciences’ outstanding shares for $200 a share through a subsidiary. Prometheus Biosciences uses precision medicine to discover, develop and commercialise new therapeutic and companion diagnostic products to treat immune-mediated diseases.

article thumbnail

General Mills upgrades cereals, snacks

Drug Store News

General Mills is surprising fans with a new collection of items ranging from new cereals to cereal-inspired snacks.

104
104
article thumbnail

J&J Launches $50M Multiple Sclerosis Collaboration with Pipeline Therapeutics

PharmExec

J&J's Janssen Pharmaceutica NV collaborates with Pipeline Therapeutics in a $50 million licensing deal for oral MS drug PIPE-307, with potential earnings of up to $1 billion for Pipeline.

103
103
article thumbnail

Hikma taps Riad Mishlawi as CEO

Drug Store News

Said Darwazah will step down as acting CEO and return to his role as executive chairman.

103
103
article thumbnail

Opinion: OTC naloxone is a baby step toward making the life-saving medication accessible

STAT

In an attempt to make naloxone more accessible amid the massive human toll of the opioid crisis, the FDA recently approved over-the-counter naloxone. Naloxone is the one solution that has remained constant through the evolving opioid crisis. A safe and effective medication that can quickly reverse an overdose, it is a critical tool in the public health response to the opioid crisis.

FDA 102
article thumbnail

Real retail ecosystem

Drug Store News

Pharmacy is having a moment, and it’s coming at a critical time.

102
102
article thumbnail

Q&A: What does it mean when a clinical trial is delayed? More than you think

STAT

Frank David was just starting an independent research program on cell signaling in cancer and kidney development at a lab in Boston when he realized he’d rather be doing something else. “I figured out I was more interested in how science turned into medicine than I was in actually making and discovering new science,” he recalled.

102
102
article thumbnail

Bucked Up goes for nostalgia with Pixie Pump pre-workout

Drug Store News

Bucked Up’s Pixie Pump leverages natural ingredients to deliver long-lasting energy and focus, the company said.

101
101
article thumbnail

In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off

Fierce Pharma

In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off kdunleavy Mon, 04/17/2023 - 11:34

100
100
article thumbnail

HIMSS23: Epic taps Microsoft to integrate generative AI into EHRs with Stanford, UC San Diego as early adopters

Fierce Healthcare

HIMSS23: Epic taps Microsoft to integrate generative AI into EHRs with Stanford, UC San Diego as early adopters hlandi Mon, 04/17/2023 - 10:13

99
article thumbnail

NKGen Biotech signs agreement to merge with Graf Acquisition

Pharmaceutical Technology

NKGen Biotech, a clinical-stage natural killer (NK) cell therapy firm, has signed a definitive agreement to combine its business operations with Graf Acquisition. NKGen Biotech will become a publicly traded company, while Graf will be rebranded as NKGen Biotech. Graf is also anticipated to be listed on the New York Stock Exchange, NYSE American and Nasdaq under the ticker symbol ‘NKGN’.

98
article thumbnail

Opinion: Where are the guidelines for the production of animals with intentional genomic alterations?

STAT

Genetic engineering has the potential to transform how we raise animals for meat and other products, making food safer, improving animal health and welfare, and shrinking animal agriculture’s environmental footprint. Pigs that are less likely to induce allergic reactions in humans. Cows with short hair that are better adapted to a changing climate or others that lack horns , preventing injury to other cows or farmhands.

FDA 98
article thumbnail

How to get rid of a caffeine headache

The Checkup by Singlecare

If you are one of the 80% to 90% of adults who start your day with a cup of coffee, it’s likely you will encounter caffeine withdrawal at one time or another. Caffeine withdrawal usually occurs when you quit caffeine “cold turkey” and can cause unpleasant symptoms—one of the most common being a caffeine withdrawal headache. Some people with caffeine dependence get headaches if they miss their daily Starbucks latte by even an hour.

98
article thumbnail

Free Uber rides helped patients keep their prenatal appointments. Now the company wants insurers to pay for it

STAT

For patients of the Community of Hope and Mary’s Center clinics in Washington, D.C., getting to their medical appointments can be a challenge — many live far from public transit or lack cars. If they’re pregnant, the fallout can be especially harmful if they miss prenatal doctor visits, risking the baby’s and mother’s health.